Péter Bacsur (Peter Bacsur)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Klebsiella Pneumoniae

Disease Activity

Ulcerative Colitis

Top Venues

Therapeutic advances in gastroenterology

Expert opinion on drug safety

Diagnostics (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system. Therapeutic advances in gastroenterology 17 (2024)
Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system. Therapeutic advances in gastroenterology 17 (2024)
Bernadett Farkas, Emese Ivány, Anita Bálint, Péter Bacsur, Tamás Molnár, Klaudia Farkas
Diagnostic and Therapeutic Challenges in Severe Peristomal Pyoderma Gangrenosum. Inflammatory bowel diseases (2024)
Péter Bacsur, Ákos Iliás, Tamás Resál, Diána Kata, Tamás Molnár, Klaudia Farkas
Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary. Alimentary pharmacology & therapeutics 58 (2) (2023)
Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Judit Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone. Expert opinion on drug safety (2023)
Péter Bacsur, Mariann Rutka, András Asbóth, Tamás Resál, Kata Judit Szántó, Boldizsár Jójárt, Anita Bálint, Eszter Ari, Walliyulahi Ajibola, Bálint Kintses, Tamás Fehér, Daniella Pigniczki, Renáta Bor, Anna Fábián, József Maléth, Zoltán Szepes, Klaudia Farkas, Tamás Molnár
Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls. Therapeutic advances in gastroenterology 16 (2023)
Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Judit Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone. Expert opinion on drug safety (2023)
Tamás Resál, Péter Bacsur, Miklós Horváth, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, János Fekete, Klaudia Farkas, Pál Miheller, Tamás Molnár
Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination. Therapeutic advances in gastroenterology 16 (2023)
Renáta Bor, Béla Vasas, Anna Fábián, Mónika Szücs, Zsófia Bősze, Anita Bálint, Mariann Rutka, Klaudia Farkas, Tibor Tóth, Tamás Resál, Péter Bacsur, Tamás Molnár, Zoltán Szepes
Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions. Diagnostics (Basel, Switzerland) 13 (17) (2023)
Boldizsár Jójárt, Tamás Resál, Diána Kata, Tünde Molnár, Péter Bacsur, Viktória Szabó, Árpád Varga, Kata Judit Szántó, Petra Pallagi, Imre Földesi, Tamás Molnár, József Maléth, Klaudia Farkas
Plasminogen activator inhibitor 1 is a novel faecal biomarker for monitoring disease activity and therapeutic response in inflammatory bowel diseases. Journal of Crohn's & colitis (2023)
Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patricia Sarlos, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Ágnes Csontos, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study. Therapeutic advances in gastroenterology 15 (2022)
Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patricia Sarlos, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Ágnes Csontos, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study. Therapeutic advances in gastroenterology 15 (2022)
Anita Bálint, Klaudia Farkas, Orsolya Méhi, Bálint Kintses, Bálint Márk Vásárhelyi, Eszter Ari, Csaba Pál, Tamara Madácsy, József Maléth, Kata Judit Szántó, István Nagy, Mariann Rutka, Péter Bacsur, Diána Szűcs, Zoltán Szepes, Ferenc Nagy, Anna Fábián, Renáta Bor, Ágnes Milassin, Tamás Molnár
Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)